STK17A

STK17A

Target · Serine/threonine kinase

STK17A Serine/threonine kinase 17a · DRAK1

STK17A (serine/threonine kinase 17a, also known as DRAK1) is a nuclear serine/threonine-protein kinase of the DAP kinase family. It acts as a positive regulator of apoptosis and as a regulator of cellular reactive oxygen species. Browse Assay Genie's current range of STK17A research reagents below, or read on for the biology behind the target.

Nuclear proteinApoptosis-inducing kinaseDAP kinase family member
414 aa
Protein length
~47 kDa
Molecular weight
7p13
Gene locus
EC 2.7.11.1
Enzyme class
Target information

What is STK17A (serine/threonine kinase 17a)?

STK17A is a serine/threonine-protein kinase (EC 2.7.11.1) that acts as a positive regulator of apoptosis. UniProt also describes a role for the protein in regulating cellular reactive oxygen species. The NCBI Gene summary notes that the protein has apoptosis-inducing activity, which makes it a useful point of study for researchers interested in how kinase signalling relates to programmed cell death and redox balance.

The STK17A gene encodes an autophosphorylated nuclear protein with a protein kinase domain, and UniProt lists its subcellular location as the nucleus. The protein belongs to the protein kinase superfamily, within the CAMK Ser/Thr protein kinase family and the DAP kinase subfamily. HGNC places the gene in the death associated protein kinases group, and RefSeq describes it as a member of the DAP kinase-related apoptosis-inducing protein kinase family.

The protein is also known as DRAK1, a name that reflects its relationship to the DAP kinases. Its earlier approved HGNC name, serine/threonine kinase 17a (apoptosis-inducing), points to the same defining activity. Researchers working with the STK17A protein, whether through an STK17A antibody, an STK17A ELISA kit or analysis of the STK17A gene, typically do so in studies of apoptosis, nuclear kinase activity and oxidative stress responses. Related serine/threonine kinases are listed below for comparison across the wider kinase landscape.

Apoptosis research

STK17A is a positive regulator of apoptosis, and its apoptosis-inducing activity makes it relevant to studies of programmed cell death.

Reactive oxygen species biology

UniProt annotates STK17A as a regulator of cellular reactive oxygen species, linking the kinase to redox homeostasis studies.

Nuclear kinase signalling

The autophosphorylated, nuclear STK17A protein with its kinase domain is a subject for studying kinase activity within the nucleus.

DAP kinase family studies

As a DAP kinase subfamily member within the CAMK family, STK17A supports comparative work on death-associated protein kinases.

Background

STK17A frequently asked questions

What does STK17A do?

STK17A is a serine/threonine-protein kinase that acts as a positive regulator of apoptosis. UniProt also reports that it regulates cellular reactive oxygen species. According to NCBI Gene, it is an autophosphorylated nuclear protein with a protein kinase domain and apoptosis-inducing activity.

What other names is STK17A known by?

STK17A is also called DRAK1, which is its alias in HGNC. Its full approved name is serine/threonine kinase 17a, and a previous name was serine/threonine kinase 17a (apoptosis-inducing). UniProt lists the protein as serine/threonine-protein kinase 17A.

Which protein family does STK17A belong to?

STK17A belongs to the protein kinase superfamily, the CAMK Ser/Thr protein kinase family and the DAP kinase subfamily. HGNC groups it with the death associated protein kinases. Check the datasheet of any product for its validated reactivity, as orthologue information is not given here.

Explore

Related targets

Other serine/threonine kinases that share the STK nomenclature, useful for comparative kinase and apoptosis research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UEE5; product specifications from Assay Genie datasheets.

STK17A Product listing